Published July 2019
| Version v1
Journal article
Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors
Creators
- 1. Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam (Netherlands)
Description
As patients with centrally located lung tumors are at increased risk of toxicity with stereotactic ablative radiation therapy (SABR), we performed stereotactic magnetic resonance (MR)-guided adaptive radiation therapy (SMART) for such patients. We retrospectively analyzed the benefits of daily on-table plan adaptation.
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2019.03.035;
- PII
- S0360301619305528;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 104
- Journal Issue
- 4
- Journal Page Range
- p. 933-941
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55057181
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- HEALTH HAZARDS; LUNGS; NEOPLASMS; PATIENTS; RADIOTHERAPY; TOXICITY
- Descriptors DEC
- BODY; DISEASES; HAZARDS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY
Optional Information
- Copyright
- Copyright (c) 2019 Elsevier Inc. All rights reserved.